Advanced imaging to detect early pancreatic cancer during surgery
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study tests a special high-resolution camera that can see tiny details during pancreatic surgery to help doctors detect early-stage pancreatic cancer or precancerous growths called IPMNs. The goal is to improve how well surgeons can identify and remove diseased tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You have pancreatic cancer or IPMN (a growth in the pancreas that may become cancer)
- You are scheduled to have surgery to remove part or all of your pancreas
- You are able to give informed consent to participate
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses MRI scans to see how well chemotherapy and radiation work in people with borderline resectable pancreatic cancer – a type where surgery might be possible but is risky. The goal is to find the best way to measure tumor response so doctors can make better treatment decisions.
This trial tests whether an artificial intelligence (AI) system can help doctors spot abnormal or cancerous growths in the pancreas during a special endoscopic procedure called pancreatoscopy. If successful, it could improve the accuracy of detecting these growths and help guide treatment decisions.
This trial uses advanced imaging to detect pancreatic cancer early and track how well treatment is working. It may help if you have pancreatic cancer that can be surgically removed, either right away or after chemotherapy.
This trial tests whether a targeted antibody with a fluorescent dye can help surgeons see and remove pancreatic cancer during planned surgery. It’s an early-phase study, so the main goal is to see if the approach is safe and useful around the time of the operation.
This trial studies whether adding an MRI scan improves the selection of people with pancreatic cancer who may benefit from surgery. It focuses on patients without liver spread and with tumors that are borderline or likely removable.
This trial uses an artificial-intelligence tool to help detect pancreatic cancer earlier and track people at higher risk. You may be asked to complete questionnaires and have imaging tests like MRI or CT to see how well the approach works.
Hear when a new Pancreatic Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.